Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Wysocki

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Expert Opinion on Biological Therapy|September 9, 2008
Cardiovascular complications associated with biological therapies for breast cancerP J Wysocki, H Wysocki
Expert Opinion on Biological Therapy|December 1, 2001
Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancerS Nawrocki, P J Wysocki, A Mackiewicz
Expert Opinion on Biological Therapy|December 1, 2001
Recent developments in retroviral gene delivery systemsP J Wysocki, P Grabarczyk, A Mackiewicz
Expert Opinion on Biological Therapy|December 1, 2001
The 14th European Immunology Meeting--EFIS 2000. 23-27 September 2000, Poznañ, PolandP J Wysocki, S Nawrocki, A Mackiewicz
Expert Opinion on Biological Therapy|March 5, 2004
The 34th Annual Meeting of the German Society of Immunology with participation of the Polish Society of Experimental and Clinical ImmunologyP J Wysocki, M Mackiewicz-Wysocka, A Mackiewicz
Expert Opinion on Biological Therapy|May 5, 2007
Recent developments in renal cell cancer immunotherapyP J Wysocki, J Zolnierek, C Szczylik, et al.
Advances in Experimental Medicine and Biology|January 5, 2002
Improving the retroviral vector (RV) systems for immunotherapy of cancerP Grabarczyk, K Gryska, P J Wysocki, et al.
Expert Opinion on Biological Therapy|January 9, 2003
Genetically modified dendritic cells--a new, promising cancer treatment strategy?P J Wysocki, P Grabarczyk, M Mackiewicz-Wysocka, et al.
Cancer Gene Therapy|February 20, 2010
Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancerP J Wysocki, U Kazimierczak, W Suchorska, et al.
Advances in Experimental Medicine and Biology|January 5, 2002
IL-6 and GM-CSF in tumor rejection model of renal cell cancerP J Wysocki, D W Kowalczyk, D Izycki, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|September 9, 2008
Cardiovascular complications associated with biological therapies for breast cancerP J Wysocki, H Wysocki
Expert Opinion on Biological Therapy|December 1, 2001
Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancerS Nawrocki, P J Wysocki, A Mackiewicz
Expert Opinion on Biological Therapy|December 1, 2001
Recent developments in retroviral gene delivery systemsP J Wysocki, P Grabarczyk, A Mackiewicz
Expert Opinion on Biological Therapy|December 1, 2001
The 14th European Immunology Meeting--EFIS 2000. 23-27 September 2000, Poznañ, PolandP J Wysocki, S Nawrocki, A Mackiewicz
Expert Opinion on Biological Therapy|March 5, 2004
The 34th Annual Meeting of the German Society of Immunology with participation of the Polish Society of Experimental and Clinical ImmunologyP J Wysocki, M Mackiewicz-Wysocka, A Mackiewicz
Expert Opinion on Biological Therapy|May 5, 2007
Recent developments in renal cell cancer immunotherapyP J Wysocki, J Zolnierek, C Szczylik, et al.
Advances in Experimental Medicine and Biology|January 5, 2002
Improving the retroviral vector (RV) systems for immunotherapy of cancerP Grabarczyk, K Gryska, P J Wysocki, et al.
Expert Opinion on Biological Therapy|January 9, 2003
Genetically modified dendritic cells--a new, promising cancer treatment strategy?P J Wysocki, P Grabarczyk, M Mackiewicz-Wysocka, et al.
Cancer Gene Therapy|February 20, 2010
Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancerP J Wysocki, U Kazimierczak, W Suchorska, et al.
Advances in Experimental Medicine and Biology|January 5, 2002
IL-6 and GM-CSF in tumor rejection model of renal cell cancerP J Wysocki, D W Kowalczyk, D Izycki, et al.
Pageof 2